May is National Brain Tumor Awareness Month. Driven by advancement in research, surgical techniques, genetic discoveries, and much more, it has never been a better time to take action on brain tumors. The National Brain Tumor Society (NBTS), an organization whose mission is to unrelentingly invest in, mobilize, and unite our community to discover a […]
Watch KTUL-TV’s Good Day Tulsa visit Oklahoma CyberKnife and learn about brain tumors. Dr. Diane Heaton, radiation oncologist and Medical Director at Oklahoma CyberKnife and Dr. Michael Thambuswamy, neurosurgeon at Oklahoma Spine and Brain Institute, discuss benign and metastatic intracranial tumors and how they are treated with the latest technology.
National Acoustic Neuroma Awareness Week is May 7 – 13, 2017. The week is dedicated to raising awareness about acoustic neuroma (AN), a slow-growing benign tumor of the vestibular cochlear nerve that connects the ear to the brain. This nerve has two distinct parts, one part associated with transmitting sound and the other with sending […]
A recent study, published in The Journal of the American Medical Association, an international peer-reviewed medical journal, found that patients with three or fewer metastatic brain tumors who received treatment with stereotactic radiosurgery (SRS) had less cognitive deterioration three months after treatment than patients who received SRS combined with whole brain radiation therapy (WBRT). For […]
May is National Brain Tumor Awareness Month. According to the National Brain Tumor Society, who is committed to improving the lives of all those affected by brain tumors, more than 69,000 Americans will be diagnosed with a primary brain tumor this year. A brain tumor is an abnormal growth of tissue in the brain or […]
A recent study published in the International Journal of Radiation Oncology assessed survival rates of metastatic brain tumor patients treated with stereotactic radiosurgery (SRS) alone, compared to those treated with a combination of SRS and whole-brain radiation therapy (WBRT). Researchers analyzed patient data from three of the largest clinical trials of SRS and WBRT conducted […]
Each year, the American Cancer Society releases an annual report highlighting projections and forecasts in the cancer industry regarding estimated numbers of new cases and deaths, current cancer incidence, mortality, and survival statistics and other information on symptoms, risks, early detection methods and treatment options. In 2015, there will be an estimated 1,658,370 new cancer […]
2014 marks the 20th anniversary of CyberKnife technology. Oklahoma CyberKnife is proud to commemorate this milestone. Developed in 1994 at Stanford by Dr. John Adler, the concept was conceived with the goal of treating tumors throughout the body with radiosurgery, a treatment that at the time was restricted to head and neck tumors. Over the […]
Lung tumors, prostate cancer, and brain tumors are among our center’s most frequently treated diseases, yet CyberKnife® can also treat other diseases with stereotactic body radiation therapy. Arteriovenous Malformation (AVM): AVMs are abnormal connections between arteries and veins that commonly occur in the brain and spine. Blood typically enters the brain through arteries, moves to […]
May is Brain Tumor Awareness Month, a time to educate others, fundraise and offer support to brain tumor patients. Here’s what you should know about brain tumors: More than 170,000 Americans will face a brain tumor diagnosis this year. Brain tumors can be treated with surgery, radiation therapy, chemotherapy or a mixture of these therapies. Metastatic […]